4893 items matching your search terms.

Correlation of phase 2 trials results with outcomes of phase 3 trials of investigational agents in locally advanced and metastatic pancreas cancer

Tang, M. Chen, J. Goldstein, D. Links, M. Lord, S. Marschner, I. Simes, J. Lee, C.K.

RCT evidence should drive clinical practice: a day without randomisation is a day without progress

Tarnow-Mordi, W. Cruz, M. Morris, J. M. Mol, B. W.
BJOG, 2017     DOI:10.1111/1471-0528.14468

Delayed versus immediate cord clamping in preterm infants

Tarnow-Mordi, W. Morris, J. Kirby, A. Robledo, K. Askie, L. Brown, R. Evans, N. Finlayson, S. Fogarty, M. Gebski, V. Ghadge, A. Hague, W. Isaacs, D. Jeffery, M. Keech, A. Kluckow, M. Popat, H. Sebastian, L. Aagaard, K. Belfort, M. Pammi, M. Abdel-Latif, M. Reynolds, G. Ariff, S. Sheikh, L. Chen, Y. Colditz, P. Liley, H. Pritchard, M. de Luca, D. de Waal, K. Forder, P. Duley, L. El-Naggar, W. Gill, A. Newnham, J. Simmer, K. Groom, K. Weston, P. Gullam, J. Patel, H. Koh, G. Lui, K. Marlow, N. Morris, S. Sehgal, A. Wallace, E. Soll, R. Young, L. Sweet, D. Walker, S. Watkins, A. Wright, I. Osborn, D. Simes, J. Australian Placental Transfusion Study Collaborative, Group
NEW ENGLAND JOURNAL OF MEDICINE, 2017     DOI:10.1056/NEJMoa1711281

Parallel multicentre randomised trial of a clinical trial question prompt list in patients considering participation in phase 3 cancer treatment trials

Tattersall, M. H. Jefford, M. Martin, A. Olver, I. Thompson, J. F. Brown, R. F. Butow, P. N.
BMJ OPEN, 2017     DOI:10.1136/bmjopen-2016-012666

Evaluating the addition of oxaliplatin to single agent fluoropyrimidine in the treatment of locally advanced rectal cancer: a systematic review and meta-analysis

Thavaneswaran, S. Kok, P. S. Price, T.
EXPERT REVIEW OF ANTICANCER THERAPY, 2017     DOI:10.1080/14737140.2017.1369881

Establishing core outcome domains in hemodialysis: report of the Standardized Outcomes in Nephrology-Hemodialysis (SONG-HD) Consensus Workshop

Tong, A. Manns, B. Hemmelgarn, B. Wheeler, D. C. Evangelidis, N. Tugwell, P. Crowe, S. Van Biesen, W. Winkelmayer, W. C. O'Donoghue, D. Tam-Tham, H. Shen, J. I. Pinter, J. Larkins, N. Youssouf, S. Mandayam, S. Ju, A. Craig, J. C. Song-Hd Investigators
AMERICAN JOURNAL OF KIDNEY DISEASES, 2017     DOI:10.1053/j.ajkd.2016.05.022

Oral supplementation with bovine whey-derived Ig-rich fraction and lactoferrin improves SCORAD and DLQI in atopic dermatitis

Tong, P. L. West, N. P. Cox, A. J. Gebski, V. J. Watts, A. M. Dodds, A. de St Groth, B. F. Cripps, A. W. Shumack, S.
JOURNAL OF DERMATOLOGICAL SCIENCE, 2017     DOI:10.1016/j.jdermsci.2016.11.009

Connexins and microRNAs: Interlinked players in regulating islet function?

Umrani, M. R. Joglekar, M. V. Somerville Glover, E. Wong, W. Hardikar, A. A.
ISLETS, 2017     DOI:10.1080/19382014.2017.1331192

Efficacy of a novel antibody-drug conjugate, ABT-414, as monotherapy in epidermal growth factor receptor amplified, recurrent glioblastoma

van den Bent, M. Gan, H. Lassman, A. Kumthekar, P. Butowski, N. Nabors, L. Simes, J. Maag, D. Reardon, D.

Efficacy of depatuxizumab mafodotin (ABT-414) monotherapy in patients with EGFR-amplified, recurrent glioblastoma: results from a multi-center, international study

van den Bent, M. Gan, H. K. Lassman, A. B. Kumthekar, P. Merrell, R. Butowski, N. Lwin, Z. Mikkelsen, T. Nabors, L. B. Papadopoulos, K. P. Penas-Prado, M. Simes, J. Wheeler, H. Walbert, T. Scott, A. M. Gomez, E. Lee, H. J. Roberts-Rapp, L. Xiong, H. Bain, E. Ansell, P. J. Holen, K. D. Maag, D. Reardon, D. A.
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017     DOI:10.1007/s00280-017-3451-1

Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study

van den Bent, M. J. Baumert, B. Erridge, S. C. Vogelbaum, M. A. Nowak, A. K. Sanson, M. Brandes, A. A. Clement, P. M. Baurain, J. F. Mason, W. P. Wheeler, H. Chinot, O. L. Gill, S. Griffin, M. Brachman, D. G. Taal, W. Ruda, R. Weller, M. McBain, C. Reijneveld, J. Enting, R. H. Weber, D. C. Lesimple, T. Clenton, S. Gijtenbeek, A. Pascoe, S. Herrlinger, U. Hau, P. Dhermain, F. van Heuvel, I. Stupp, R. Aldape, K. Jenkins, R. B. Dubbink, H. J. Dinjens, W. N. M. Wesseling, P. Nuyens, S. Golfinopoulos, V. Gorlia, T. Wick, W. Kros, J. M.
LANCET, 2017     DOI:10.1016/S0140-6736(17)31442-3

Antiplatelet agents and the prevention of spontaneous preterm birth: a systematic review and meta-analysis

van Vliet, E. O. Askie, L. A. Mol, B. W. Oudijk, M. A.
OBSTETRICS AND GYNECOLOGY, 2017     DOI:10.1097/AOG.0000000000001848

Reducing the costs of chronic kidney disease while delivering quality health care: a call to action

Vanholder, R. Annemans, L. Brown, E. Gansevoort, R. Gout-Zwart, J. J. Lameire, N. Morton, R. L. Oberbauer, R. Postma, M. J. Tonelli, M. Biesen, W. V. Zoccali, C. European Kidney Health, Alliance
NAT REV NEPHROL, 2017     DOI:10.1038/nrneph.2017.63

Further approaches to reduce the cost of renal replacement therapy

Vanholder, R. Annemans, L. Brown, E. Gansevoort, R. Gout-Zwart, J. J. Lameire, N. Morton, R. L. Oberbauer, R. Postma, M. J. Tonelli, M. Van Biesen, W. Zoccali, C. European Kidney Health, Alliance
NAT REV NEPHROL, 2017     DOI:10.1038/nrneph.2017.136

Accuracy and prognostic significance of oncologists estimates and scenarios for survival time in a randomised phase 2 trial of regorafenib in advanced gastric cancer

Vasista, A. Martin, A. Pavlakis, N. Sjoquist, K. Snow, S. Jonker, D. Chua, Y.J. Epstein, R. Bonaventura, A. Khasraw, M. Varma, S.C. Singhal, N. Ransom, D. Aubin, F. Burkes, R. L. Lim, H. Lemay, F. Begbie, S. Stockler, M. Kiely, B.
, 2017     DOI:10.1093/annonc/mdx369